Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2003
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/13/2003WO2003093258A2 Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
11/13/2003WO2003093257A1 Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentaidenoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/13/2003WO2003093256A1 Method for producing gamma-butyrolactone
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093208A1 Homogenous process for the hydrogenation of carboxylic acids and derivatives thereof
11/13/2003WO2003092666A1 Calcium-containing tissue strengthening agents and use thereof
11/13/2003WO2003029213A9 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003US20030212170 Heat and oxidation resistance; phorostability; color photography
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212128 Crystalline particles of escitalopram oxalate having a median particle size of >40 mu m; cystallization by gradually cooling the solution of dissolved escitalopram oxalate at a controlled cooling rate; adding crystals of escitalopram oxalate and holding; isolating particles
11/13/2003US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1359890A2 Primary intermediates for oxidative coloration of hair
11/12/2003EP1359887A1 Primary intermediates for oxidative coloration of hair
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003CN1455766A Novel 1,2-diphenylethene derivatives for treatment of immune diseases
11/12/2003CN1454894A Method of preparing 2,5-dihydro furan
11/12/2003CN1127536C Stabilisers and anti-ozonants for elastomers
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/12/2003CN1127342C Medicine for reducing intraocular pressure
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646135 Continuous process for the enantioselective hydrogenation of alpha ketocarbonyl compounds
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091235A1 Manufacture of ketopantolactone
11/06/2003WO2003091234A1 Biguanide derivative and therapeutic agent for diabetes containing the same
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003US20030208081 Carbocyclic ethers such as (Methyl-(3-(4-phenoxy-phenoxy)-3-phenyl-propyl)-amino)-acetic acid, used as neurotransmitter antagonists, for prophylaxis of psychological disorders
11/06/2003US20030208079 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for proph7ylaxis of cardiovascular disorders
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207923 Treatment of autoimmune disease, inflammation and allergy; inhibits release of tumour necrosis factor
11/06/2003US20030207922 Diketoacids useful as inhibitors of viral polymerases, in particular hepatitis C virus, RNA dependent RNA polymerase, hepatitis B virus polymerase and reverse transcriptase of human immunodeficiency virus
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207893 Antihistamines such as (5-Chloro-1H-indol-2-yl)-(4-methyl-piperazin-1-yl)-methanone, used as antiinflammatory, antiarthritic or bronchodilator agents and/or immunology modulators
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207871 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
11/06/2003US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
11/06/2003US20030207812 Cd45 inhibitors
11/06/2003US20030207431 Properties of mycophenolic acid inhibition of IMPDH (inosine-5'-monophosphate dehydrogenase) that allow the development of the immunoassay; drug conjugates with an uncompetitive inhibitor of IMPDH, mycophenolic acid
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/06/2003US20030207153 Luminescent device with a triarylamine compound
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/05/2003EP1359139A1 Terphenyl compounds bearing substituted amino groups
11/05/2003EP1359136A2 Polymeric resin compounds and their preparation
11/05/2003EP1358909A1 Heteroaryl-phenyl derivatives as factor xa inhibitors for use as antithrombotic and anticoagulant agents
11/05/2003EP1358183A2 Cysteine protease inhibitors
11/05/2003EP1358176A2 Inhibitors of cruzipain and other cysteine proteases
11/05/2003EP1358175A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
11/05/2003EP1358174A2 Inhibitors of cruzipain and other cysteine proteases
11/05/2003EP1246813B1 Method for the preparation of citalopram
11/05/2003EP1087956B1 A reference compound for use in the analysis of levosimendan batches
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP0975617B1 Inhibitors of cholesterol esterase
11/05/2003EP0774966B1 Benzofuran compounds, compositions, and methods
11/05/2003EP0770064B1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
11/05/2003CN1453362A Chemical-enzymatic synthesis process for optical-enriched rose oxide
11/05/2003CN1453273A Benzene anhydride recovering and refining method from rectified residue
11/05/2003CN1126751C Method for reducing color number of benzene anhydride
11/05/2003CN1126545C Ophthalmic preparations
11/04/2003US6642424 Diels-Alder process; antitumor agents
11/04/2003US6642396 Converting pentose at boiling point and separating vapor phase
11/04/2003US6642393 Such as 2,5-(dihydroxybenzenecarboxylic octane)-dibenzoate-3,3',4,4' -tetracarboxylic acid anhydride for producing polyimides or polyamic acides having low water absorption; for use in cosmetics, aeronautics, and electronics
11/04/2003US6642255 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
11/04/2003US6642180 Biphenyl-substituted cyclic ketoenols as pesticides
10/2003
10/30/2003WO2003089615A2 Antiviral inhibitions of capsid proteins
10/30/2003WO2003089421A1 Antiviral lactone-ureas
10/30/2003WO2003089420A2 Recovery and purification of anhydro sugar alcohols from a vapor stream
10/30/2003WO2003089404A1 Naphthalene amides as potassium channel openers
10/30/2003WO2003089125A2 Hydrogenation catalyst, preparation thereof, and method for the preparation of gamma-butyrolactone from maleic anhydride using the catalyst
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2002102765A3 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2-[18f]-fluoroethyl)-l-tyrosine
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204100 Formylating a protected phenol compound, reacting the product compound with a metal hydride and thereafter with an alkylmagnesium halide, and cyclizing the product
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203943 A chemical complex of niacinamide and H2 histamine receptor antagonist which is selected from ranitidine, cimetidine, famotidine, nizatidine and derivatives; a medicament or a dietary- supplement for immunomodulation in a mammal
1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 472